Effectiveness of Dasatinib in Adult Patients With Chronic Myeloid Leukemia in China: A Multicenter, Registry Study

NCT02389972 · clinicaltrials.gov ↗

COMPLETED

Status

128

Enrollment

INDUSTRY

Sponsor class

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Interventions

DRUG: Dasatinib

Sponsor

Bristol-Myers Squibb